VanEck Associates’s Immunomedics Inc IMMU Stock Holding History

VanEck Associates’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-296,489	Closed	-$25.2M	–	1052
2020 Q3	$25.2M	Buy	+296,489	New	+$15M	0.08%	156

VanEck Associates's IMMU Position: Q4 2020 in Review

VanEck Associates sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 296,489 shares — an estimated $25.2M sold.

VanEck Associates first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $25.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

VanEck Associates reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
VanEck Associates sold 296,489 Immunomedics Inc shares in Q4 2020, an estimated $25.2M.
VanEck Associates first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
VanEck Associates's Immunomedics Inc position peaked at $25.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on VanEck Associates's 13F filing for Q4 2020, filed 9 Feb 2021.